# Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

> **NCT04774237** · PHASE2 · COMPLETED · sponsor: **Visus Therapeutics** · enrollment: 18 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** BRIMOCHOL™
- **DRUG:** BRIMOCHOL™ F
- **DRUG:** Carbachol

## Key facts

- **NCT ID:** NCT04774237
- **Lead sponsor:** Visus Therapeutics
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-24
- **Primary completion:** 2021-10-19
- **Final completion:** 2021-10-19
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04774237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04774237, "Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04774237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*